4//SEC Filing
Shah Tushar 4
Accession 0001104659-21-095512
CIK 0001819576other
Filed
Jul 22, 8:00 PM ET
Accepted
Jul 23, 6:15 PM ET
Size
5.7 KB
Accession
0001104659-21-095512
Insider Transaction Report
Form 4
Liquidia CorpLQDA
Shah Tushar
CMO and Head of R&D
Transactions
- Award
Stock Option (Right to Buy)
2021-07-21+10,000→ 10,000 totalExercise: $2.54Exp: 2031-07-21→ Common Stock (10,000 underlying)
Footnotes (1)
- [F1]The option vests over a four-year period with 25% of the shares of common stock underlying the option vesting on the one-year anniversary of the grant date and the remaining 75% of the shares of common stock underlying the option vesting in equal monthly installments thereafter, becoming fully vested on July 21, 2025; provided, however, that notwithstanding the foregoing vesting schedule, 50% of the shares of common sock underlying the option will vest upon U.S. Food and Drug Administration (FDA) tentative approval of the Issuer's New Drug Application for LIQ861.
Documents
Issuer
Liquidia Corp
CIK 0001819576
Entity typeother
Related Parties
1- filerCIK 0001487632
Filing Metadata
- Form type
- 4
- Filed
- Jul 22, 8:00 PM ET
- Accepted
- Jul 23, 6:15 PM ET
- Size
- 5.7 KB